Hospital Ruber Internacional
Medication treatment for Parkinson's disease in Spain typically costs from $1,800 to $3,200. The total expense depends on the drug regimen, city, and clinic tier. In the US, similar treatments cost around $6,500 on average. Patients can save approximately 62% by choosing Spanish private clinics. These quotes usually include neurologist consultations and initial dose titration protocols.
Bookimed Expert Insight: Choosing a clinic like Centro Médico Teknon provides access to JCI-accredited care used by elite athletes. While basic medication costs are standardized, the value lies in specialized multidisciplinary teams. Clinics with large patient volumes, such as Hospital HM Madrid, offer more precise diagnostic imaging. This ensures pharmacological protocols are optimized early, potentially reducing long-term medication adjustments and related costs.
Why choose Spain for medication treatment for Parkinson's disease?
Access advanced Medication treatment for Parkinson's disease solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Medication treatment for Parkinson's disease | from $1,000 | from $2,000 | from $1,800 |
Day 1
Day 2
Day 3-7
Week 2
Week 3
Week 4
Post-Treatment
Please note, the treatment process and results can vary for each individual.
Principal investigator of 100+ clinical trials in neuroscience – Dr. Arroyo González heads the Neurology Department at Quironsalud Madrid.
Dr. Romero Imbroda, a Fellow of the European Board of Neurology, leads the Neurology Unit at Quirónsalud Marbella with a focus on Parkinson's disease.
Head of the Department of Neurosurgery at HM Hospitales Clinic – specializes in advanced treatments for neurological conditions.
The doctor is a distinguished neurologist specializing in epilepsy, currently leading the epilepsy department at HM Delfos Hospital in Spain. With a PhD from Bonn University and a specialization in neurology from Pontificia Universidad Católica de Chile, the doctor has extensive experience in treating neurological disorders.
As a professor at UPF University, the doctor has contributed significantly to the field through research and publications on topics such as cognitive impairments in Alzheimer patients and drug-resistant epilepsy. The doctor is actively involved in professional organizations like SEN and the European Reference Network.